Skip to main content
. 2019 Jun 20;14(6):e0218091. doi: 10.1371/journal.pone.0218091

Table 2. Some changes in MDA-MB231 spheroids after treatment with SCTT peptide.

Radius(μm) Av. Vol.(μm3) Ave. no. of cells/spheroids Viability%
MDA-MB231 93+/-12 3369282 315+/-30 94
MDA-MB231+ SCTT 48+/-5 463247 127+/-13 33